Aysha Arshad
Overview
Explore the profile of Aysha Arshad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
701
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Al-Khatib S, Arshad A, Balk E, Das S, Hsu J, Joglar J, et al.
Circulation
. 2015 Sep;
133(14):e575-86.
PMID: 26399661
Objective: To review the literature systematically to determine whether noninvasive or invasive risk stratification, such as with an electrophysiological study of patients with asymptomatic pre-excitation, reduces the risk of arrhythmic...
12.
Tompkins C, Kutyifa V, Arshad A, McNitt S, Polonsky B, Wang P, et al.
J Cardiovasc Electrophysiol
. 2015 May;
26(8):862-871.
PMID: 25929699
Introduction: Studies suggest that women with ischemic heart disease are less likely to experience appropriate ICD therapies for ventricular arrhythmias (VT/VF). We evaluated the influence of sex on arrhythmic events...
13.
Arshad A, Steinberg J, Mittal S
Europace
. 2014 Jul;
16(10):1481.
PMID: 25031233
No abstract available.
14.
Maytin M, Wilkoff B, Brunner M, Cronin E, Love C, Bongiorni M, et al.
Heart Rhythm
. 2014 May;
11(9):1613-8.
PMID: 24854215
Background: In November 2011, the Food and Drug Administration issued a class I recall of Riata and Riata ST implantable cardioverter-defibrillator leads. Management recommendations regarding the recall have remained controversial....
15.
Arshad A, Johnson C, Mittal S, Buch E, Hamam I, Tran T, et al.
Pacing Clin Electrophysiol
. 2014 May;
37(6):665-73.
PMID: 24797604
Background: There are a variety of periprocedural anticoagulation strategies for atrial fibrillation (AF) ablation, including the use of dabigatran. It is unclear which strategy is superior. Objective: To compare the...
16.
Steinberg J, Palekar R, Sichrovsky T, Arshad A, Preminger M, Musat D, et al.
Heart Rhythm
. 2014 Feb;
11(5):771-6.
PMID: 24508206
Background: The ablation of atrial fibrillation (AF) using pulmonary vein isolation is indicated when patients do not respond favorably to medical therapy. Successful procedures are accomplished in the majority of...
17.
Garikipati N, Mittal S, Chaudhry F, Musat D, Sichrovsky T, Preminger M, et al.
Am J Cardiol
. 2014 Jan;
113(5):840-4.
PMID: 24406108
Cardiac resynchronization therapy (CRT) has been shown to improve survival and symptoms in patients with severe left ventricular (LV) dysfunction, congestive heart failure, and prolonged QRS duration. LV lead placement...
18.
Mittal S, Shaw R, Michel K, Palekar R, Arshad A, Musat D, et al.
Heart Rhythm
. 2013 Dec;
11(4):595-601.
PMID: 24333543
Background: Cardiac implantable electronic device (CIED) infection is associated with morbidity and mortality. Objectives: To determine the incidence and risk factors for CIED infection, to develop a scoring index for...
19.
Musat D, Adhaduk M, Preminger M, Arshad A, Sichrovsky T, Steinberg J, et al.
Am J Cardiol
. 2013 Aug;
112(9):1379-83.
PMID: 23972343
The calculation of the corrected QT interval (QTc) is particularly problematic in patients during atrial fibrillation (AF). The aims of this study were to compare the QTc calculated using Bazett's...
20.
Mittal S, Pokushalov E, Romanov A, Ferrara M, Arshad A, Musat D, et al.
Heart Rhythm
. 2013 Aug;
10(11):1598-604.
PMID: 23911429
Background: In patients with atrial flutter who undergo cavotricuspid isthmus ablation, long-term electrocardiographic (ECG) monitoring may identify new onset of atrial fibrillation (AF). Objectives: To ascertain, through the use of...